• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Wavelight announces two IOL approvals

Article

Wavelight has announced the receipt of two regulatory approvals for its intraocular lenses (IOLs), thus expanding its intraocular product range.

Wavelight has announced the receipt of two regulatory approvals for its intraocular lenses (IOLs), thus expanding its intraocular product range.

The first approval was for the Lentis L-403 lens, which has a very large optic and is made of the company?s proprietary HydroSmart acrylic material. This lens is particularly recommended for anterior segment procedures.

Although the firm admits that it will continue to supply its existing, hydrophilic lenses to customers, it is focusing much of its attention on lenses made of the advanced acrylic materials, which contain very sharp, square edges.

The second approval was for the company?s three-piece hydrophobic acrylic lens.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.